Synaptic and complement markers in extracellular vesicles in multiple sclerosis

Synaptic loss is a feature of multiple sclerosis pathology that can be seen even in normal-appearing gray matter. Opsonization of synapses with complement components may underlie pathologic synapse loss. We sought to determine whether circulating neuronal-enriched and astrocytic-enriched extracellul...

Full description

Saved in:
Bibliographic Details
Published in:Multiple sclerosis Vol. 27; no. 4; p. 509
Main Authors: Bhargava, Pavan, Nogueras-Ortiz, Carlos, Kim, Sol, Delgado-Peraza, Francheska, Calabresi, Peter A, Kapogiannis, Dimitrios
Format: Journal Article
Language:English
Published: England 01.04.2021
Subjects:
ISSN:1477-0970, 1477-0970
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Synaptic loss is a feature of multiple sclerosis pathology that can be seen even in normal-appearing gray matter. Opsonization of synapses with complement components may underlie pathologic synapse loss. We sought to determine whether circulating neuronal-enriched and astrocytic-enriched extracellular vesicles (NEVs and AEVs) provide biomarkers reflecting complement-mediated synaptic loss in multiple sclerosis. From plasma of 61 people with multiple sclerosis (46 relapsing-remitting multiple sclerosis (RRMS) and 15 progressive MS) and 31 healthy controls, we immunocaptured L1CAM + NEVs and GLAST + AEVs. We measured pre- and post-synaptic proteins synaptopodin and synaptophysin in NEVs and complement components (C1q, C3, C3b/iC3b, C4, C5, C5a, C9, Factor B, and Factor H) in AEVs, total circulating EVs, and neat plasma. We found lower levels of NEV synaptopodin and synaptophysin in MS compared to controls (  < 0.0001 for both). In AEVs, we found higher levels of multiple complement cascade components in people with MS compared to controls; these differences were not noted in total EVs or neat plasma. Strikingly, there were strong inverse correlations between NEV synaptic proteins and multiple AEV complement components in MS, but not in controls. Circulating EVs could identify synaptic loss in MS and suggest a link between astrocytic complement production and synaptic loss.
AbstractList Synaptic loss is a feature of multiple sclerosis pathology that can be seen even in normal-appearing gray matter. Opsonization of synapses with complement components may underlie pathologic synapse loss. We sought to determine whether circulating neuronal-enriched and astrocytic-enriched extracellular vesicles (NEVs and AEVs) provide biomarkers reflecting complement-mediated synaptic loss in multiple sclerosis. From plasma of 61 people with multiple sclerosis (46 relapsing-remitting multiple sclerosis (RRMS) and 15 progressive MS) and 31 healthy controls, we immunocaptured L1CAM + NEVs and GLAST + AEVs. We measured pre- and post-synaptic proteins synaptopodin and synaptophysin in NEVs and complement components (C1q, C3, C3b/iC3b, C4, C5, C5a, C9, Factor B, and Factor H) in AEVs, total circulating EVs, and neat plasma. We found lower levels of NEV synaptopodin and synaptophysin in MS compared to controls (  < 0.0001 for both). In AEVs, we found higher levels of multiple complement cascade components in people with MS compared to controls; these differences were not noted in total EVs or neat plasma. Strikingly, there were strong inverse correlations between NEV synaptic proteins and multiple AEV complement components in MS, but not in controls. Circulating EVs could identify synaptic loss in MS and suggest a link between astrocytic complement production and synaptic loss.
Synaptic loss is a feature of multiple sclerosis pathology that can be seen even in normal-appearing gray matter. Opsonization of synapses with complement components may underlie pathologic synapse loss.BACKGROUNDSynaptic loss is a feature of multiple sclerosis pathology that can be seen even in normal-appearing gray matter. Opsonization of synapses with complement components may underlie pathologic synapse loss.We sought to determine whether circulating neuronal-enriched and astrocytic-enriched extracellular vesicles (NEVs and AEVs) provide biomarkers reflecting complement-mediated synaptic loss in multiple sclerosis.OBJECTIVEWe sought to determine whether circulating neuronal-enriched and astrocytic-enriched extracellular vesicles (NEVs and AEVs) provide biomarkers reflecting complement-mediated synaptic loss in multiple sclerosis.From plasma of 61 people with multiple sclerosis (46 relapsing-remitting multiple sclerosis (RRMS) and 15 progressive MS) and 31 healthy controls, we immunocaptured L1CAM + NEVs and GLAST + AEVs. We measured pre- and post-synaptic proteins synaptopodin and synaptophysin in NEVs and complement components (C1q, C3, C3b/iC3b, C4, C5, C5a, C9, Factor B, and Factor H) in AEVs, total circulating EVs, and neat plasma.METHODSFrom plasma of 61 people with multiple sclerosis (46 relapsing-remitting multiple sclerosis (RRMS) and 15 progressive MS) and 31 healthy controls, we immunocaptured L1CAM + NEVs and GLAST + AEVs. We measured pre- and post-synaptic proteins synaptopodin and synaptophysin in NEVs and complement components (C1q, C3, C3b/iC3b, C4, C5, C5a, C9, Factor B, and Factor H) in AEVs, total circulating EVs, and neat plasma.We found lower levels of NEV synaptopodin and synaptophysin in MS compared to controls (p < 0.0001 for both). In AEVs, we found higher levels of multiple complement cascade components in people with MS compared to controls; these differences were not noted in total EVs or neat plasma. Strikingly, there were strong inverse correlations between NEV synaptic proteins and multiple AEV complement components in MS, but not in controls.RESULTSWe found lower levels of NEV synaptopodin and synaptophysin in MS compared to controls (p < 0.0001 for both). In AEVs, we found higher levels of multiple complement cascade components in people with MS compared to controls; these differences were not noted in total EVs or neat plasma. Strikingly, there were strong inverse correlations between NEV synaptic proteins and multiple AEV complement components in MS, but not in controls.Circulating EVs could identify synaptic loss in MS and suggest a link between astrocytic complement production and synaptic loss.CONCLUSIONCirculating EVs could identify synaptic loss in MS and suggest a link between astrocytic complement production and synaptic loss.
Author Calabresi, Peter A
Bhargava, Pavan
Kapogiannis, Dimitrios
Nogueras-Ortiz, Carlos
Delgado-Peraza, Francheska
Kim, Sol
Author_xml – sequence: 1
  givenname: Pavan
  orcidid: 0000-0002-7947-9418
  surname: Bhargava
  fullname: Bhargava, Pavan
  organization: Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
– sequence: 2
  givenname: Carlos
  surname: Nogueras-Ortiz
  fullname: Nogueras-Ortiz, Carlos
  organization: Laboratory of Clinical Investigation, National Institutes of Aging, Baltimore, MD, USA
– sequence: 3
  givenname: Sol
  surname: Kim
  fullname: Kim, Sol
  organization: Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
– sequence: 4
  givenname: Francheska
  surname: Delgado-Peraza
  fullname: Delgado-Peraza, Francheska
  organization: Laboratory of Clinical Investigation, National Institutes of Aging, Baltimore, MD, USA
– sequence: 5
  givenname: Peter A
  surname: Calabresi
  fullname: Calabresi, Peter A
  organization: Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
– sequence: 6
  givenname: Dimitrios
  surname: Kapogiannis
  fullname: Kapogiannis, Dimitrios
  organization: Laboratory of Clinical Investigation, National Institutes of Aging, Baltimore, MD, USA/Biomedical Research Center, National Institute on Aging, National Institute of Health, Baltimore, MD, USA/ Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32669030$$D View this record in MEDLINE/PubMed
BookMark eNpNUE1LxDAUDLLifujdk-TopZq85qM5yuKqsLAH9VyS9gnRNq1JK-6_t-oKnmZ4M-8xb5ZkFrqAhJxzdsW51tc8lyBkIYGZCQ07IgsutM6Y0Wz2j8_JMqVXxpjWuTwh8xyUMixnC7J73AfbD76iNtS06tq-wRbDQFsb3zAm6gPFzyHaCptmbGykH5h81eCP0o7N4KcNmqZJ7JJPp-T4xTYJzw64Is-b26f1fbbd3T2sb7ZZJaEYMjBMysq4KZHLFXBEY6CQlXDcoQSubIFKYK2xVugcr4FZsFKDBOOMMrAil793-9i9j5iGsvXpO6MN2I2pBAFCCK6UnqwXB-voWqzLPvrpuX35VwJ8AWB8YJA
CitedBy_id crossref_primary_10_1111_ejn_70090
crossref_primary_10_1186_s12987_021_00299_4
crossref_primary_10_3389_fcell_2020_581882
crossref_primary_10_1186_s40035_024_00418_9
crossref_primary_10_1002_jev2_12459
crossref_primary_10_3390_genes15060772
crossref_primary_10_1007_s12035_025_04909_2
crossref_primary_10_1016_j_bbalip_2021_159092
crossref_primary_10_3390_ijms22169011
crossref_primary_10_1186_s43556_021_00040_5
crossref_primary_10_1212_NXI_0000000000200420
crossref_primary_10_1093_cei_uxaf003
crossref_primary_10_4103_1673_5374_389359
crossref_primary_10_1002_acn3_52040
crossref_primary_10_1002_wsbm_1594
crossref_primary_10_1186_s13195_023_01303_9
crossref_primary_10_1007_s11910_022_01227_1
crossref_primary_10_1038_s41582_025_01080_z
crossref_primary_10_3390_ijms22158163
crossref_primary_10_1002_alz_13066
crossref_primary_10_3389_fmolb_2023_1254834
crossref_primary_10_1002_eji_202250228
crossref_primary_10_1002_ctm2_70346
crossref_primary_10_3389_fnagi_2021_682115
crossref_primary_10_3390_ijms25137371
crossref_primary_10_3390_life12111943
crossref_primary_10_3390_proteomes12030021
crossref_primary_10_3389_fimmu_2025_1569503
crossref_primary_10_1002_jex2_70059
crossref_primary_10_1016_j_bbi_2023_06_025
crossref_primary_10_1177_1352458520971816
crossref_primary_10_1055_a_2335_0149
crossref_primary_10_3390_biomedicines12102245
crossref_primary_10_3389_fimmu_2023_1145649
crossref_primary_10_1016_j_nbd_2024_106663
crossref_primary_10_1016_j_envres_2021_112316
crossref_primary_10_1177_13524585221124307
crossref_primary_10_1186_s12974_024_03147_y
crossref_primary_10_3389_fimmu_2022_842023
crossref_primary_10_1097_WCO_0000000000001058
crossref_primary_10_1002_jex2_35
crossref_primary_10_1093_brain_awad341
crossref_primary_10_3389_fnins_2024_1426700
crossref_primary_10_1186_s12974_020_02024_8
crossref_primary_10_3390_cells10030686
crossref_primary_10_3389_fimmu_2022_1055050
crossref_primary_10_1016_j_bja_2024_07_040
crossref_primary_10_1002_acn3_51334
crossref_primary_10_1177_13524585231195858
crossref_primary_10_1177_13524585221106290
crossref_primary_10_1212_NXI_0000000000200257
crossref_primary_10_4103_1673_5374_380879
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1177/1352458520924590
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1477-0970
ExternalDocumentID 32669030
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Intramural
GrantInformation_xml – fundername: Intramural NIH HHS
  grantid: ZIA AG000975
– fundername: Intramural NIH HHS
  grantid: Z99 AG999999
GroupedDBID ---
-TM
.2E
.2F
.2G
.2J
.2N
01A
0R~
123
18M
1~K
29M
31R
31S
31U
31X
31Y
31Z
36B
39C
4.4
53G
54M
5VS
7X7
88E
8FI
8FJ
8R4
8R5
AABMB
AABOD
AACKU
AACMV
AACTG
AADUE
AAEJI
AAEWN
AAGGD
AAGLT
AAGMC
AAJIQ
AAJOX
AAJPV
AAKGS
AANSI
AAPEO
AAPII
AAQDB
AAQXH
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAXOT
AAYTG
AAZBJ
ABAFQ
ABAWC
ABAWP
ABCCA
ABCJG
ABDWY
ABEIX
ABFWQ
ABHFT
ABHKI
ABHQH
ABIDT
ABJIS
ABJNI
ABJZC
ABKRH
ABLUO
ABNCE
ABPGX
ABPNF
ABQKF
ABQXT
ABRHV
ABUJY
ABUWG
ABVFX
ABVVC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACFYK
ACGBL
ACGFO
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLHI
ACLZU
ACNXM
ACOFE
ACOXC
ACPRK
ACROE
ACRPL
ACSIQ
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADDLC
ADEBD
ADEIA
ADMPF
ADNBR
ADNMO
ADNON
ADRRZ
ADSTG
ADTBJ
ADUCT
ADUKL
ADVBO
ADYCS
ADZYD
ADZZY
AECGH
AECVZ
AEDTQ
AEKYL
AENEX
AEPTA
AEQLS
AERKM
AESZF
AEUHG
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFKBI
AFKRA
AFKRG
AFMOU
AFQAA
AFUIA
AFVCE
AFWMB
AGHKR
AGKLV
AGNHF
AGPXR
AGQPQ
AGWFA
AGWNL
AHDMH
AHHFK
AHMBA
AIGRN
AJABX
AJEFB
AJGYC
AJMMQ
AJSCY
AJUZI
AJVBE
AJXAJ
AJXGE
ALIPV
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
ANDLU
ARTOV
ASPBG
AUTPY
AVWKF
AYAKG
AZFZN
AZQEC
B3H
B8M
B8O
B8R
B8Z
B93
B94
BBRGL
BDDNI
BENPR
BKIIM
BKNYI
BKSCU
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
BYIEH
CAG
CBRKF
CCPQU
CDWPY
CFDXU
CGR
COF
CORYS
CQQTX
CS3
CUTAK
CUY
CVF
DB0
DC-
DC0
DD-
DD0
DE-
DF0
DO-
DOPDO
DU5
DV7
DV9
D~Y
EBS
ECM
EIF
EJD
EMOBN
F5P
FD6
FEDTE
FHBDP
FYUFA
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HMCUK
HVGLF
HZ~
J8X
K.F
K.J
K9-
M0R
M1P
N9A
NPM
O9-
P.B
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
Q1R
Q2X
Q7K
Q7L
Q7R
Q7U
Q7X
Q82
Q83
ROL
S01
SASJQ
SAUOL
SCNPE
SDB
SFB
SFC
SFK
SFN
SFT
SGA
SGO
SGP
SGR
SGV
SGX
SGZ
SHG
SNB
SPJ
SPQ
SPV
SQCSI
STM
UKHRP
XJT
ZONMY
ZPPRI
ZRKOI
ZSSAH
7X8
AJHME
ID FETCH-LOGICAL-c528t-29055c9b007b3621ee99285c4b1be5216a8e64ed7ed6ebb1d20a2a572529b9692
IEDL.DBID 7X8
ISICitedReferencesCount 57
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000542432200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1477-0970
IngestDate Sun Sep 28 06:10:25 EDT 2025
Mon Jul 21 06:06:37 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Extracellular vesicles
astrocytes
synaptic dysfunction
complement
biomarkers
multiple sclerosis
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c528t-29055c9b007b3621ee99285c4b1be5216a8e64ed7ed6ebb1d20a2a572529b9692
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-7947-9418
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/7744427
PMID 32669030
PQID 2424441667
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2424441667
pubmed_primary_32669030
PublicationCentury 2000
PublicationDate 2021-04-01
PublicationDateYYYYMMDD 2021-04-01
PublicationDate_xml – month: 04
  year: 2021
  text: 2021-04-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Multiple sclerosis
PublicationTitleAlternate Mult Scler
PublicationYear 2021
SSID ssj0007735
Score 2.534779
Snippet Synaptic loss is a feature of multiple sclerosis pathology that can be seen even in normal-appearing gray matter. Opsonization of synapses with complement...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 509
SubjectTerms Biomarkers
Complement Activation
Complement System Proteins
Extracellular Vesicles
Humans
Multiple Sclerosis
Title Synaptic and complement markers in extracellular vesicles in multiple sclerosis
URI https://www.ncbi.nlm.nih.gov/pubmed/32669030
https://www.proquest.com/docview/2424441667
Volume 27
WOSCitedRecordID wos000542432200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA5qRbz4ftQXEbwuzWaTTXISEYuX1oIKvS15FXpwW5ta8N87Sbf0JAhe9rDLwjD7ZebL5NsZhO5I4YgtBIBX5j5jWtpMSmczw_TIld7ChsymYROi35fDoRo0BbfQyCpXMTEFajexsUbeib8xQOouS3E__czi1Kh4utqM0NhErQKoTES1GK67hQuRBmzmDGwhSpD1MWUnB-LBgCpTAhsQrsjvBDMlmu7-f008QHsNxcQPS0wcog1fH6GdXnOIfoxeXr9rDZHCYl07nDTlqUaIP6JUZxbwuMYQsmc6FvWjShUvfEjqufhkpUDEAe5Aih2HE_TefXp7fM6auQqZ5VTOM6oI5zY2QxQG8lfuvVJUcstMbjyk81JLXzLvhIevZUzuKNFUc0E5VUaVip6irXpS-3OEpZHOcF7GrnLMcVjshFhbeDpimjPP2uh25aoKcBvt1rWffIVq7aw2Olv6u5ouG2xUQCkBIwW5-MPbl2iXRplJEtNcodYIVq2_Rtt2MR-H2U0CBFz7g94P5V6_sw
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synaptic+and+complement+markers+in+extracellular+vesicles+in+multiple+sclerosis&rft.jtitle=Multiple+sclerosis&rft.au=Bhargava%2C+Pavan&rft.au=Nogueras-Ortiz%2C+Carlos&rft.au=Kim%2C+Sol&rft.au=Delgado-Peraza%2C+Francheska&rft.date=2021-04-01&rft.issn=1477-0970&rft.eissn=1477-0970&rft.volume=27&rft.issue=4&rft.spage=509&rft_id=info:doi/10.1177%2F1352458520924590&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-0970&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-0970&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-0970&client=summon